Quality Assurance System

Uncompromising Quality Standards

Quality assurance is the foundation of everything we do at Josias Pharmaceutical. Our quality assurance system is designed to ensure that every product we source, store, and distribute meets the highest standards of safety, efficacy, and regulatory compliance. We believe that quality is not a department or a function; it is a mindset that permeates every aspect of our operations.

Our QA system has been developed in accordance with internationally recognised standards, including Good Distribution Practice (GDP), Good Manufacturing Practice (GMP) principles as applied to distribution, and ISO 9000 quality management requirements. This integrated approach ensures consistency, traceability, and accountability across our entire supply chain.

Testing and Evaluation

Every product that enters our distribution network undergoes rigorous testing and evaluation before it is released for supply. Our incoming goods inspection process includes visual examination of products and packaging, verification of certificates of analysis against product specifications, batch documentation review and reconciliation, temperature monitoring data review for cold chain products, and packaging integrity checks.

Products that fail to meet any of our acceptance criteria are immediately quarantined and subjected to investigation. Our quality team works with the manufacturer to determine the root cause of any non-conformance and to implement corrective actions that prevent recurrence.

Batch Release

Our batch release process is a critical quality gateway that ensures only products meeting all specified requirements are released for distribution. Each batch release decision is made by a qualified and authorised member of our quality team, based on a comprehensive review of all relevant documentation and test results.

The batch release process covers verification of manufacturer batch records and certificates of analysis, confirmation of product registration and regulatory approval status in the destination market, review of storage and transportation conditions during transit, and confirmation that all serialisation and track-and-trace requirements have been met.

No product is released for distribution until all batch release criteria have been satisfied. This disciplined approach ensures that our clients and their patients receive only products of verified quality.

Continuous Improvement

Quality assurance is not a static process. At Josias Pharmaceutical, we are committed to the continuous improvement of our quality systems, processes, and capabilities. Our quality improvement programme is driven by systematic analysis of quality data, including non-conformance trends, customer feedback, audit findings, and key performance indicators.

We conduct regular internal audits of our quality management system to verify its ongoing effectiveness and identify opportunities for improvement. The results of these audits, together with quality performance data, are reviewed by senior management at regular intervals to ensure that quality remains a strategic priority.

Our investment in quality assurance reflects our fundamental belief that the pharmaceutical industry carries a profound responsibility to patients. Every process, every check, and every decision within our QA system is designed with one ultimate objective: protecting patient safety.